Search Filters

Sponsors/Funders See All +

Phase See All +

Medical Condition See All +

Medicine See All +

This is a keyword search. It will find studies with your keywords in the study information.
To find studies using the keyword search, enter your keyword search term below, e.g. "lung cancer" or a trial identification number.
You can also search studies by Sponsor/Funder, Phase, Medical Condition or Medicine by using the search filters on the left.

Keyword Search Clear All

To initiate a Research Proposal or to Ask a Question about studies, please do the following:

Login and create an account.
Click on the Study ID to view Study Details.
If you cannot find the specific study you are looking for, click here to submit an Enquiry

Export All Studies >

2988 Results:

Sponsor	Studies ↑	Description	Ready to Share	Created

Eisai	EISAI-E2007-A001-206	A Double-Blind, Placebo-Controlled, Dose-Escalation, Parallel-Group Study of E2007 Given as Adjunctive Therapy in Patients With Refractory Partial Seizures	No	11/30/2018

Eisai	EISAI-E2007-G000-208	A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Explore the Safety And Tolerability of Doses of E2007 up to a Maximum of 12 mg In Patients With Refractory Partial Seizures	No	2/17/2021

Eisai	EISAI-E2007-G000-235	A Randomized, Double-blind, Placebo-controlled, Parallel-group Study With an Open-label Extension Phase to Evaluate the Effect of Perampanel (E2007) on Cognition, Growth, Safety, Tolerability, and Pharmacokinetics When Administered as an Adjunctive Therapy in Adolescents (12 to Less Than 18 Years of Age) With Inadequately Controlled Partial-onset Seizures	No	11/30/2018

Eisai	EISAI-E2007-G000-304	A Double-Blind, Placebo-Controlled, Dose-Escalation, Parallel-Group Study to Evaluate the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures	Yes	11/30/2018

Eisai	EISAI-E2007-G000-305	A Double-Blind, Placebo-Controlled, Dose-Escalation, Parallel-Group Study to Evaluate the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures	Yes	11/30/2018

Eisai	EISAI-E2007-G000-306	A Double-Blind, Placebo-Controlled, Dose-Escalation, Parallel-Group Study to Evaluate the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures	Yes	11/30/2018

Eisai	EISAI-E2007-G000-332	A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures	Yes	1/31/2017

Eisai	EISAI-E2007-G000-332EXT	A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures	Yes	1/31/2017

Eisai	EISAI-E2007-J000-335	A Double-blind, Placebo-controlled, Parallel-group Study With an Open-label Extension Phase to Evaluate the Efficacy and Safety of Perampanel (E2007) Administered as an Adjunctive Therapy in Subjects With Refractory Partial-onset Seizures	No	11/30/2018

Eisai	EISAI-E2007-J000-341	An Open-label Extension Study to Evaluate the Safety and Tolerability of Perampanel (E2007) Administered as an Adjunctive Therapy in Epilepsy Subjects	No	2/17/2021

First 1 2 3 4 5 ... Last